Advisor(s)
Abstract(s)
Introduction: Primary Aldosteronism (PA) is the most prevalent cause of secondary hypertension.
Nevertheless, there is no portuguese multicenter study characterizing PA patients.
Aims: To characterize the clinical presentation, diagnostic workup, treatment and follow-up of patients
with confirmed PA.
Methods: Retrospective multicenter study of PA patients followed in 9 portuguese hospitals.
Results: Sixty-three cases were selected with a mean age of diagnosis of 52.1 ± 13.1 years, 9.9 years
after the diagnosis of hypertension. At presentation, 37 cases (60.7%) had hypertension, 11 (22.9%) had
resistant hypertension and 20 (32.8%) of patients had hipokalemia (mean 3.2 mmol/L). Baseline laboratory
showed a mean serum aldosterone of 33.4ng/dL, plasmatic renin activity (PRA) of 0.2ng/mL/h with an
aldosterone/PRA ratio of 97.1. Confirmatory testing was performed with saline infusion in 55 patients
(positive in 84.4%) and captopril test in 14 (positive in 85.7%). Imaging showed adenomas in 55 cases,
hyperplasia in 2 and bilateral cases in 8. Arterial venous sampling (AVS) was performed in 9 patients
(14,5%) and was conclusive in 1. Iodocholesterol scintigraphy was done in 14 cases (22%) with unilateral
fixation in 9 and no fixation in 4. Patients were treated with laparoscopic adrenalectomy in 28 cases
(58.3%) and mineralocorticoid receptor antagonists in 20 cases (41.7%). The surgical treated group had
less duration of hypertension (8 versus 14 years, p = 0.002), higher prevalence of anti-hypertensive drugs
at presentation (100 versus 75% p = 0.009) and bigger tumour size (1.8 versus 1.5 cm, p = 0.022). During
follow-up there was a trend towards a greater proportion of patients with no hypertension improvement
in the medical treatment group (29.4% versus 7.4%, p = 0.089).
Conclusion: This is the first Portuguese PA multicenter study. It suggests that PA remains an under-
-diagnosed condition with a significant delay in diagnosis. Surgical treated patients had a more aggressive
disease and showed a trend towards better hypertension control.
Description
Keywords
Hiperaldosteronismo Aldosterona
Citation
Rev Port Endocrinol Diabetes Metab. 2016;xxx(xx):xxx–xxx